Covered recipient · General Payments record
ALEXANDER M CASE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,915.44
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $705.16 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $346.13 | 19 |
| Ardelyx, Inc. | $125.00 | 1 |
| Madrigal Pharmaceuticals | $114.02 | 4 |
| Regeneron Healthcare Solutions, Inc. | $36.08 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.90 | 1 |
| Lilly USA, LLC | $22.04 | 1 |
| PFIZER INC. | $18.31 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.50 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888313 | CMS |
| ABBVIE INC. | $10.98 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888315 | CMS |
| ABBVIE INC. | $12.94 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888317 | CMS |
| ABBVIE INC. | $23.86 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888319 | CMS |
| ABBVIE INC. | $21.29 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888321 | CMS |
| ABBVIE INC. | $10.45 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888323 | CMS |
| ABBVIE INC. | $4.39 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888325 | CMS |
| ABBVIE INC. | $22.80 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888327 | CMS |
| ABBVIE INC. | $22.87 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888329 | CMS |
| ABBVIE INC. | $11.02 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888331 | CMS |
| ABBVIE INC. | $10.05 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888333 | CMS |
| ABBVIE INC. | $25.78 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888335 | CMS |
| ABBVIE INC. | $20.35 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888337 | CMS |
| ABBVIE INC. | $25.95 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888339 | CMS |
| ABBVIE INC. | $13.58 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888341 | CMS |
| ABBVIE INC. | $14.89 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888343 | CMS |
| ABBVIE INC. | $27.61 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888345 | CMS |
| ABBVIE INC. | $25.57 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888347 | CMS |
| ABBVIE INC. | $21.25 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106888349 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.68 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147019358 | CMS |
| Ardelyx, Inc. | $125.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146721111 | CMS |
| Lilly USA, LLC | $22.04 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135483347 | CMS |
| Madrigal Pharmaceuticals | $17.24 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144188618 | CMS |
| Madrigal Pharmaceuticals | $40.01 | 09/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144188620 | CMS |
| Madrigal Pharmaceuticals | $30.47 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144188622 | CMS |
| Madrigal Pharmaceuticals | $26.30 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144188624 | CMS |
| PFIZER INC. | $18.31 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131938617 | CMS |
| Regeneron Healthcare Solutions, Inc. | $36.08 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114281968 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.90 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137723484 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.